Clinical trial Recruiting at 1 site Observational Ages 50 to 75

Using kinematic theory to help diagnose Parkinson's disease

Official title: Contribution of the Kinematic Theory in the Early Differential Diagnosis of the Parkinson's Disease

Run by Centre hospitalier de l'Université de Montréal (CHUM) · NCT06161636 · Data updated 2026-11-12

This study is testing new ways to use movement analysis to help tell the difference between people with Parkinson's disease, related conditions, and healthy individuals.

Quick facts

Study typeObservational
Ages50 Years to 75 Years
SexAll
Enrollment90 (estimated)
SponsorCentre hospitalier de l'Université de Montréal (CHUM)
Academic / other
Locations1 site (Montreal, Quebec)
StatusRecruiting
StartedFebruary 19, 2020
Main results expectedDecember 2028
Study endsDecember 2028
Registry record updatedFebruary 14, 2025
Trial IDNCT06161636 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include individuals aged 50-75 diagnosed with Parkinsonism for 6 years or less, as well as healthy volunteers without neurological history.

Probably not a fit

Patients with major neurocognitive disorders or other significant neurological conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to differentiate between patients with Parkinson's disease, related syndromes, and healthy individuals using advanced kinematic analysis. It will employ various non-invasive techniques, including oculovisual measurements, to assess motor performance and identify potential biomarkers for clinical diagnosis. The study will compare the reliability of different parametric approaches in distinguishing these groups, focusing on the early stages of Parkinsonism. While it has strengths in its innovative methodology, it acknowledges limitations due to the absence of multimodal confirmation methods.

Why it matters

Potential benefit: If successful, this study could enhance early diagnosis and differentiation of Parkinson's disease, leading to better-targeted treatments.

How similar studies have gone: While this approach is innovative, similar studies have shown promise in using non-invasive techniques for diagnosing Parkinson's disease.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Being diagnosed with Parkinsonism including idiopathic Parkinson's disease or a related syndrome;
* Have motor symptoms of Parkinsonism for 6 years or less;
* Be a healthy volunteer subject in good general health with no prior neurological history;
* Age between 50-75 years old;
* If applicable, be able to safely leave home in the morning without having taken antiparkinsonian medication for the past 12 hours.

Exclusion Criteria:

* Major neurocognitive disorders;
* History of other neurological conditions, such as ischemic or hemorrhagic stroke, paralysis of a limb, traumatic brain injury, epilepsy, orofacial dystonia, essential tremor;
* History of oromandibular or laryngeal procedures;
* Uncorrected deafness;
* Any contraindication to pupillary dilation.

Where it's running

  • CHUM/Université de Montréal
    Montreal, Quebec, Canada
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.